Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAs
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAs
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 21, Pages 13206
Publisher
MDPI AG
Online
2022-10-30
DOI
10.3390/ijms232113206
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The emerging roles of exosomal long non‐coding RNAs in bladder cancer
- (2022) Qiang Liu JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Exosomes as a new frontier of cancer liquid biopsy
- (2022) Dan Yu et al. Molecular Cancer
- Mutually exclusive mutation profiles define functionally related genes in muscle invasive bladder cancer
- (2022) Ami G. Sangster et al. PLoS One
- Identification of Prognostic Biomarkers for Bladder Cancer Based on DNA Methylation Profile
- (2022) Shumei Zhang et al. Frontiers in Cell and Developmental Biology
- Improved urine DNA methylation panel for early bladder cancer detection
- (2022) Qixun Fang et al. BMC CANCER
- A novel and sensitive DNA methylation marker for the urine-based liquid biopsies to detect bladder cancer
- (2022) Leihong Deng et al. BMC CANCER
- Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiences
- (2022) Shuyang Yao et al. Scientific Reports
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Extracellular Vesicles as Biomarkers Carriers in Bladder Cancer: Diagnosis, Surveillance, and Treatment
- (2021) Natalia Georgantzoglou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exosomes in bladder cancer: novel biomarkers and targets
- (2021) Hao Geng et al. Journal of Zhejiang University-SCIENCE B
- Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis
- (2021) Chunyu Zhang et al. Frontiers in Oncology
- Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin
- (2021) Carissa E. Chu et al. CLINICAL CANCER RESEARCH
- Potent Inhibition of Nicotinamide N-Methyltransferase by Alkene-Linked Bisubstrate Mimics Bearing Electron Deficient Aromatics
- (2021) Yongzhi Gao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Diagnostic and prognostic role of BTA, NMP22, survivin and cytology in urothelial carcinoma
- (2021) Yu-Wen Gong et al. Translational Cancer Research
- The Roles of CircRNAs in Bladder Cancer: Biomarkers, Tumorigenesis Drivers, and Therapeutic Targets
- (2021) Fajuan Cheng et al. Frontiers in Cell and Developmental Biology
- Esterase-Sensitive Prodrugs of a Potent Bisubstrate Inhibitor of Nicotinamide N-Methyltransferase (NNMT) Display Cellular Activity
- (2021) Matthijs J. van Haren et al. Biomolecules
- The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update
- (2021) Roberto Campagna et al. Biomolecules
- Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?
- (2021) Nada Humayun-Zakaria et al. Translational Andrology and Urology
- The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma
- (2021) Richard Cathomas et al. EUROPEAN UROLOGY
- Evaluation of DNA methylation in promoter regions of hTERT, TWIST1, VIM and NID2 genes in Moroccan bladder cancer patients
- (2021) Meryem El Azzouzi et al. Cancer Genetics
- Identification of Key Genes Associated with Progression and Prognosis of Bladder Cancer through Integrated Bioinformatics Analysis
- (2021) Shiv Verma et al. Cancers
- Biomarkers in Bladder Cancer Surveillance
- (2021) Sukumar S. Sugeeta et al. Frontiers in Surgery
- EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinoma
- (2020) Jonathan Rosenberg et al. JOURNAL OF CLINICAL ONCOLOGY
- A Multiplex Test Assessing MiR663ame and VIMme in Urine Accurately Discriminates Bladder Cancer from Inflammatory Conditions
- (2020) Sara Monteiro-Reis et al. Journal of Clinical Medicine
- Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review
- (2020) Rui Batista et al. Diagnostics
- European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
- (2020) J. Alfred Witjes et al. EUROPEAN UROLOGY
- Telomeres and telomerase in oncogenesis (Review)
- (2020) Tomasz Trybek et al. Oncology Letters
- Overview of VI-RADS in Bladder Cancer
- (2020) Martina Pecoraro et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Non-coding RNA in bladder cancer
- (2020) Yi Li et al. CANCER LETTERS
- Bladder cancer hunting: A microfluidic paper‐based analytical device
- (2020) Qingyun Jiang et al. ELECTROPHORESIS
- Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non–Muscle-Invasive Bladder Cancer
- (2020) Joaquim Bellmunt et al. CANCER RESEARCH
- Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer
- (2020) Xu Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Urinary biomarkers in bladder cancer: A review of the current landscape and future directions
- (2020) Kenrick Ng et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer
- (2020) Constance Le Goux et al. Scientific Reports
- Clinical Validation of a Urine Test (Uromonitor-V2®) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients
- (2020) Caroline A. Sieverink et al. Diagnostics
- FGFR3 – a Central Player in Bladder Cancer Pathogenesis?
- (2020) Margaret A. Knowles Bladder Cancer
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update
- (2019) Marko Babjuk et al. EUROPEAN UROLOGY
- PLEKHS1: A new molecular marker predicting risk of progression of non‑muscle‑invasive bladder cancer
- (2019) G�raldine Pignot et al. Oncology Letters
- Bladder cancer cell‑secreted exosomal miR‑21 activates the PI3K/AKT pathway in macrophages to promote cancer progression
- (2019) Fan Lin et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study
- (2019) Rui Batista et al. Frontiers in Genetics
- A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder
- (2018) Teruo Inamoto et al. DISEASE MARKERS
- Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System)
- (2018) Valeria Panebianco et al. EUROPEAN UROLOGY
- Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study
- (2018) Run-Qi Guo et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Urine cell-based DNA methylation classifier for monitoring bladder cancer
- (2018) Antoine G. van der Heijden et al. Clinical Epigenetics
- Ewing sarcoma
- (2018) Thomas G. P. Grünewald et al. Nature Reviews Disease Primers
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
- (2018) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018
- (2018) Marcus George Kwesi Cumberbatch et al. EUROPEAN UROLOGY
- Potential of circulating biomarkers in liquid biopsy diagnostics
- (2018) Joo Chuan Yeo et al. BIOTECHNIQUES
- Circulating miRNA panels for specific and early detection in bladder cancer
- (2018) Wataru Usuba et al. CANCER SCIENCE
- Detection and surveillance of bladder cancer using urine tumor DNA
- (2018) Jonathan C. Dudley et al. Cancer Discovery
- Prognostic Impact of a 12-gene Progression Score in Non–muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study
- (2017) Lars Dyrskjøt et al. EUROPEAN UROLOGY
- Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy
- (2017) Kim E.M. van Kessel et al. JOURNAL OF UROLOGY
- FGFR3 , TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study
- (2017) Willemien Beukers et al. JOURNAL OF UROLOGY
- Mutations in the promoter of the telomerase geneTERTcontribute to tumorigenesis by a two-step mechanism
- (2017) Kunitoshi Chiba et al. SCIENCE
- Evaluation of the NMP22 BladderChek test for detecting bladder cancer: a systematic review and meta-analysis
- (2017) Zijie Wang et al. Oncotarget
- The prognostic and diagnostic value of circulating tumor cells in bladder cancer and upper tract urothelial carcinoma: a meta-analysis of 30 published studies
- (2017) Zheng Zhang et al. Oncotarget
- Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior
- (2017) Aaron Mobley et al. Scientific Reports
- MicroRNA Expression Profile Identifies High Grade, Non-Muscle-Invasive Bladder Tumors at Elevated Risk to Progress to an Invasive Phenotype
- (2017) Sara Lenherr et al. Genes
- Bladder cancer diagnosis with CT urography: test characteristics and reasons for false-positive and false-negative results
- (2017) Tony W. Trinh et al. Abdominal Radiology
- MicroRNAs with prognostic significance in bladder cancer: a systematic review and meta-analysis
- (2017) Yongpeng Xie et al. Scientific Reports
- Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models
- (2016) P. M. Challita-Eid et al. CANCER RESEARCH
- EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin
- (2016) Samantha Cambier et al. EUROPEAN UROLOGY
- An interstitial deletion within 9p21.3 and extending beyondCDKN2Apredisposes to melanoma, neural system tumours and possible haematological malignancies
- (2016) Maria J Baker et al. JOURNAL OF MEDICAL GENETICS
- Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria
- (2016) Kim E.M. van Kessel et al. JOURNAL OF UROLOGY
- Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
- (2016) Sam S. Chang et al. JOURNAL OF UROLOGY
- Plekhs1 and Prdx3 are candidate genes responsible for mild hyperglycemia associated with obesity in a new animal model of F344-fa-nidd6 rat
- (2016) Jun KOTOH et al. JOURNAL OF VETERINARY MEDICAL SCIENCE
- miR-143 inhibits bladder cancer cell proliferation and enhances their sensitivity to gemcitabine by repressing IGF-1R signaling
- (2016) Hengbing Wang et al. Oncology Letters
- ImmunoCyt test compared to cytology in the diagnosis of bladder cancer: A meta-analysis
- (2016) HOUGUANG HE et al. Oncology Letters
- Lymphovascular invasion status at transurethral resection of bladder tumors may predict subsequent poor response of T1 tumors to bacillus Calmette-Guérin
- (2016) Keishiro Fukumoto et al. BMC Urology
- Urinary Biomarkers for Diagnosis of Bladder Cancer
- (2015) Roger Chou et al. ANNALS OF INTERNAL MEDICINE
- Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder Cancer
- (2015) Antonin Brisuda et al. UROLOGIA INTERNATIONALIS
- Surgical Advances in Bladder Cancer
- (2015) David C. Johnson et al. UROLOGIC CLINICS OF NORTH AMERICA
- Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer
- (2015) Faysal A. Yafi et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old
- (2015) Eva Compérat et al. VIRCHOWS ARCHIV
- Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer
- (2015) CÉDRIC POYET et al. Oncology Letters
- Expression and clinical significance of microRNA-21, maspin and vascular endothelial growth factor-C in bladder cancer
- (2015) HUI-HUI ZHANG et al. Oncology Letters
- MicroRNAome genome: A treasure for cancer diagnosis and therapy
- (2014) Ioana Berindan-Neagoe et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clinical significance of fibroblast growth factor receptor-3 mutations in bladder cancer: a systematic review and meta-analysis
- (2014) X. Liu et al. GENETICS AND MOLECULAR RESEARCH
- Recent Advances in Imaging Cancer of the Kidney and Urinary Tract
- (2014) Susan Hilton et al. Surgical Oncology Clinics of North America
- Increased expression of miR-222 is associated with poor prognosis in bladder cancer
- (2014) Dong-qing Zhang et al. World Journal of Surgical Oncology
- Telomerase Reverse Transcriptase Gene Promoter Mutations Help Discern the Origin of Urogenital Tumors: A Genomic and Molecular Study
- (2013) Song Wu et al. EUROPEAN UROLOGY
- International Variations in Bladder Cancer Incidence and Mortality
- (2013) Saurabh Chavan et al. EUROPEAN UROLOGY
- Extracellular vesicles: biology and emerging therapeutic opportunities
- (2013) Samir EL Andaloussi et al. NATURE REVIEWS DRUG DISCOVERY
- The Use of Molecular Analyses in Voided Urine for the Assessment of Patients with Hematuria
- (2013) Willemien Beukers et al. PLoS One
- TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism
- (2013) P. S. Rachakonda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of urine markers, white light cystoscopy and fluorescence cystoscopy in recurrence, progression and follow-up of non-muscle invasive bladder cancer
- (2013) Ilhan Karaoglu et al. WORLD JOURNAL OF UROLOGY
- Clinical features of bladder cancer in primary care
- (2012) Elizabeth A Shephard et al. BRITISH JOURNAL OF GENERAL PRACTICE
- Epidemiology and Risk Factors of Urothelial Bladder Cancer
- (2012) Maximilian Burger et al. EUROPEAN UROLOGY
- Oncogenic FGFR3 gene fusions in bladder cancer
- (2012) Sarah V. Williams et al. HUMAN MOLECULAR GENETICS
- CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma
- (2012) Sandra Rebouissou et al. JOURNAL OF PATHOLOGY
- Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation
- (2012) Thomas Reinert et al. PLoS One
- Urine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder Cancer
- (2011) Derya Tilki et al. EUROPEAN UROLOGY
- Trends in Mortality From Urologic Cancers in Europe, 1970–2008
- (2011) Cristina Bosetti et al. EUROPEAN UROLOGY
- Potential and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in Kidney, Prostate, and Bladder Cancer Including Pelvic Lymph Node Staging: A Critical Analysis of the Literature
- (2011) Gianluca Giannarini et al. EUROPEAN UROLOGY
- Incidence of Secondary Cancer Development After High-Dose Intensity-Modulated Radiotherapy and Image-Guided Brachytherapy for the Treatment of Localized Prostate Cancer
- (2011) Michael J. Zelefsky et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Three Epigenetic Biomarkers, GDF15, TMEFF2, and VIM, Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine Samples
- (2010) V. L. Costa et al. CLINICAL CANCER RESEARCH
- Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
- (2009) L. Dyrskjot et al. CANCER RESEARCH
- Lymphovascular Invasion in Transurethral Resection Specimens as Predictor of Progression and Metastasis in Patients With Newly Diagnosed T1 Bladder Urothelial Cancer
- (2009) Kang Su Cho et al. JOURNAL OF UROLOGY
- Bladder cancer
- (2009) Donald S Kaufman et al. LANCET
- Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia
- (2009) R. T. Calado et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- UroVysion FISH test for detecting urothelial cancers: Meta-analysis of diagnostic accuracy and comparison with urinary cytology testing
- (2008) Tine Hajdinjak UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now